Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
180,668,821
-
Share change
-
-1,927,779
-
Total reported value
-
$1,190,571,826
-
Put/Call ratio
-
14%
-
Price per share
-
$6.59
-
Number of holders
-
195
-
Value change
-
-$26,866,259
-
Number of buys
-
93
-
Number of sells
-
87
Institutional Holders of IMMUNOGEN INC - COMMON STOCK (IMGN) as of Q2 2021
As of 30 Jun 2021,
IMMUNOGEN INC - COMMON STOCK (IMGN) was held by
195 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
180,668,821 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, FMR LLC, STATE STREET CORP, Redmile Group, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and Clearbridge Investments, LLC.
This page lists
195
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.